Else Nutrition Commends HHS & FDA's Operation Stork Speed on Expanding Infant Formula Options
Else Nutrition Holdings (BABYF) welcomes the launch of Operation Stork Speed, a strategic initiative by the U.S. Department of Health and Human Services (HHS) and FDA aimed at expanding infant formula options. The company is actively pursuing the development of the first whole food, plant-based infant formula in the United States.
The company has established a presence in Washington D.C., engaging a healthcare lobbying firm and conducting bipartisan Congressional meetings. These efforts have led to Congressional oversight on modernized FDA guidance for plant-based, non-soy, non-dairy infant formula options.
This development follows the FDA's January 2025 release of their Long-Term National Strategy to Increase the Resiliency of the U.S. Infant Formula Market. Else Nutrition's formula focuses on using natural ingredients like almonds, buckwheat, and tapioca to create clean-label alternatives for early childhood nutrition.
Else Nutrition Holdings (BABYF) accoglie con favore il lancio di Operation Stork Speed, un'iniziativa strategica del Dipartimento della Salute e dei Servizi Umani degli Stati Uniti (HHS) e della FDA, volta ad ampliare le opzioni di latte artificiale per neonati. L'azienda sta attivamente perseguendo lo sviluppo della prima formula per neonati a base di alimenti integrali e vegetali negli Stati Uniti.
L'azienda ha stabilito una presenza a Washington D.C., collaborando con una società di lobbying nel settore sanitario e conducendo incontri bipartisan al Congresso. Questi sforzi hanno portato a un controllo da parte del Congresso sulle linee guida modernizzate della FDA per le opzioni di latte artificiale vegetale, non a base di soia e non caseario.
Questo sviluppo segue il rilascio da parte della FDA, previsto per gennaio 2025, della loro Strategia Nazionale a Lungo Termine per aumentare la resilienza del mercato del latte artificiale negli Stati Uniti. La formula di Else Nutrition si concentra sull'uso di ingredienti naturali come mandorle, grano saraceno e tapioca per creare alternative con etichetta pulita per la nutrizione dell'infanzia.
Else Nutrition Holdings (BABYF) da la bienvenida al lanzamiento de Operation Stork Speed, una iniciativa estratégica del Departamento de Salud y Servicios Humanos de EE. UU. (HHS) y la FDA destinada a ampliar las opciones de fórmula infantil. La empresa está persiguiendo activamente el desarrollo de la primera fórmula infantil a base de alimentos integrales y vegetales en los Estados Unidos.
La compañía ha establecido una presencia en Washington D.C., colaborando con una firma de cabildeo en el sector de la salud y llevando a cabo reuniones bipartidistas en el Congreso. Estos esfuerzos han llevado a una supervisión del Congreso sobre la guía modernizada de la FDA para las opciones de fórmula infantil a base de plantas, sin soja y sin lácteos.
Este desarrollo sigue el lanzamiento de la Estrategia Nacional a Largo Plazo de la FDA para aumentar la resiliencia del mercado de fórmulas infantiles en EE. UU., programado para enero de 2025. La fórmula de Else Nutrition se centra en el uso de ingredientes naturales como almendras, trigo sarraceno y tapioca para crear alternativas de etiqueta limpia para la nutrición infantil.
Else Nutrition Holdings (BABYF)는 미국 보건복지부(HHS)와 FDA의 전략적 이니셔티브인 Operation Stork Speed의 출범을 환영합니다. 이는 유아용 조제분유 옵션을 확대하기 위한 것입니다. 이 회사는 미국에서 최초의 전통식물 기반 유아용 조제분유 개발을 적극적으로 추진하고 있습니다.
회사는 워싱턴 D.C.에 사무소를 두고 건강 관리 로비 회사와 협력하며 양당의 의회 회의를 진행하고 있습니다. 이러한 노력은 식물 기반, 비콩, 비유제품 유아용 조제분유 옵션에 대한 FDA의 현대화된 지침에 대한 의회의 감독으로 이어졌습니다.
이 개발은 2025년 1월 FDA가 발표할 계획인 미국 유아용 조제분유 시장의 회복력을 높이기 위한 장기 국가 전략에 따른 것입니다. Else Nutrition의 조제분유는 아몬드, 메밀, 타피오카와 같은 자연 재료를 사용하여 어린이 영양을 위한 클린 라벨 대안을 만드는 데 중점을 두고 있습니다.
Else Nutrition Holdings (BABYF) se réjouit du lancement de Operation Stork Speed, une initiative stratégique du Département de la santé et des services sociaux des États-Unis (HHS) et de la FDA visant à élargir les options de lait infantile. L'entreprise poursuit activement le développement de la première formule infantile à base d'aliments entiers et végétaux aux États-Unis.
L'entreprise a établi une présence à Washington D.C., en collaborant avec une société de lobbying dans le secteur de la santé et en menant des réunions bipartites au Congrès. Ces efforts ont conduit à une surveillance du Congrès sur les directives modernisées de la FDA concernant les options de lait infantile à base de plantes, sans soja et sans produits laitiers.
Ce développement fait suite à la publication par la FDA, prévue pour janvier 2025, de sa stratégie nationale à long terme visant à accroître la résilience du marché américain des laits infantiles. La formule d'Else Nutrition se concentre sur l'utilisation d'ingrédients naturels tels que les amandes, le sarrasin et la tapioca pour créer des alternatives à étiquette propre pour la nutrition infantile.
Else Nutrition Holdings (BABYF) begrüßt den Start von Operation Stork Speed, einer strategischen Initiative des US-Gesundheitsministeriums (HHS) und der FDA, die darauf abzielt, die Optionen für Säuglingsnahrung zu erweitern. Das Unternehmen verfolgt aktiv die Entwicklung der ersten vollwertigen, pflanzlichen Säuglingsnahrung in den Vereinigten Staaten.
Das Unternehmen hat eine Präsenz in Washington D.C. etabliert, arbeitet mit einer Lobbyfirma im Gesundheitswesen zusammen und führt parteiübergreifende Kongressbesprechungen durch. Diese Bemühungen haben zu einer Kongressaufsicht über die modernisierten FDA-Richtlinien für pflanzliche, nicht-soja- und nicht-milchhaltige Säuglingsnahrungsoptionen geführt.
Diese Entwicklung folgt der Veröffentlichung der langfristigen nationalen Strategie der FDA zur Erhöhung der Resilienz des US-Säuglingsnahrungsmarktes, die für Januar 2025 geplant ist. Die Formel von Else Nutrition konzentriert sich auf die Verwendung natürlicher Zutaten wie Mandeln, Buchweizen und Tapioka, um saubere Alternativen für die Ernährung im frühen Kindesalter zu schaffen.
- Regulatory progress with FDA guidance supporting plant-based infant formula development
- Strategic Washington D.C. presence established with healthcare lobbying support
- Alignment with new government initiatives for infant formula market expansion
- Product not yet approved or available in the US market
- Still requires completion of clinical trials
- Faces regulatory hurdles before market entry
HHS/FDA Announcement Bolsters Else Nutrition's Momentum in Bringing its Infant Formula to Market in
As part of its commitment to bringing the first whole food, minimally processed, clean-label, plant-based infant formula to American families, Else Nutrition has been actively engaged in a robust
In January 2025, the FDA released their Long-Term National Strategy to Increase the Resiliency of the
"At Else Nutrition, we are dedicated to ensuring that families across America have access to safe, high-quality, minimally processed plant-based nutrition options," said Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. "Many infants with medical, dietary or dietary needs require such formulas. Congress has taken significant action to ensure access to these formulas and we are pleased to see the Administration continue this most important work. We applaud President Trump and Secretary Robert F. Kennedy for their leadership in launching Operation Stork Speed and look forward to collaborating with HHS and the FDA to create a modernized regulatory pathway for plant-based, non-soy, non-dairy infant formulas. By combining rigorous science with the power of natural ingredients like almonds, buckwheat, and tapioca, we are redefining early childhood nutrition to be healthier, more sustainable, and more accessible to parents seeking clean-label alternatives."
About Else Nutrition Holdings Inc.
Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.
Awards and Recognition:
- "2017 Best Health and Diet Solutions" award at
Milan 's Global Food Innovation Summit - #1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler Formula Category
- "Best Dairy Alternative" Award 2021 at World Plant-Based Expo
- Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle category
- During September 2022, Else Super Cereal reached the #1 Best Seller in Baby Cereal across all brands on Amazon
- In May 2024 Else Nutrition's Ready-to-Drink Kids Vanilla Shake Named Among the Best in Family-Friendly Products by the Prestigious Mom's Choice Awards®
TSX
Neither the TSX nor its regulation services provider (as that term is defined in the policies of the TSX) accept responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "will" or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the company's financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs, and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID-19 and that the manufacturing, broker, and supply logistic agreement with the company does not terminate. Actual results may differ from the estimates, beliefs, and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this press release. The company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
View original content to download multimedia:https://www.prnewswire.com/news-releases/else-nutrition-commends-hhs--fdas-operation-stork-speed-on-expanding-infant-formula-options-302406777.html
SOURCE Else Nutrition Holdings Inc.